General Information of Drug Off-Target (DOT) (ID: OTQEQSRT)

DOT Name OX-2 membrane glycoprotein (CD200)
Synonyms CD antigen CD200
Gene Name CD200
UniProt ID
OX2G_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00047
Sequence
MERLVIRMPFSHLSTYSLVWVMAAVVLCTAQVQVVTQDEREQLYTPASLKCSLQNAQEAL
IVTWQKKKAVSPENMVTFSENHGVVIQPAYKDKINITQLGLQNSTITFWNITLEDEGCYM
CLFNTFGFGKISGTACLTVYVQPIVSLHYKFSEDHLNITCSATARPAPMVFWKVPRSGIE
NSTVTLSHPNGTTSVTSILHIKDPKNQVGKEVICQVLHLGTVTDFKQTVNKGYWFSVPLL
LSIVSLVILLVLISILLYWKRHRNQDRGELSQGVQKMT
Function Costimulates T-cell proliferation. May regulate myeloid cell activity in a variety of tissues.
Reactome Pathway
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell (R-HSA-198933 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
14 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of OX-2 membrane glycoprotein (CD200). [1]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of OX-2 membrane glycoprotein (CD200). [2]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of OX-2 membrane glycoprotein (CD200). [3]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of OX-2 membrane glycoprotein (CD200). [4]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of OX-2 membrane glycoprotein (CD200). [5]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of OX-2 membrane glycoprotein (CD200). [6]
Panobinostat DM58WKG Approved Panobinostat affects the expression of OX-2 membrane glycoprotein (CD200). [7]
Demecolcine DMCZQGK Approved Demecolcine increases the expression of OX-2 membrane glycoprotein (CD200). [8]
Ethanol DMDRQZU Approved Ethanol decreases the expression of OX-2 membrane glycoprotein (CD200). [9]
SNDX-275 DMH7W9X Phase 3 SNDX-275 decreases the expression of OX-2 membrane glycoprotein (CD200). [5]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 affects the expression of OX-2 membrane glycoprotein (CD200). [7]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of OX-2 membrane glycoprotein (CD200). [11]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of OX-2 membrane glycoprotein (CD200). [8]
[3H]methyltrienolone DMTSGOW Investigative [3H]methyltrienolone decreases the expression of OX-2 membrane glycoprotein (CD200). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of OX-2 membrane glycoprotein (CD200). [10]
------------------------------------------------------------------------------------

References

1 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
2 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
3 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
6 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
7 The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Clin Cancer Res. 2016 May 15;22(10):2534-44. doi: 10.1158/1078-0432.CCR-15-1666. Epub 2016 Jan 5.
8 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
9 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
12 Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell. 2006 Oct;10(4):321-30.